Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
Earnings Data
Report Date
Aug 11, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.15Last Year’s EPS
0.06Same Quarter Last Year
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 05, 2025
|% Change Since: 31.83%
|Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter with significant revenue growth, subscriber expansion, and strategic partnerships, particularly in the weight loss category. However, there are expected challenges in transitioning the sexual health vertical and managing gross margins.Company Guidance
During the Hims & Hers First Quarter 2025 Earnings Call, significant guidance metrics were shared, highlighting the company's strategic trajectory and financial targets. The company anticipates generating at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030, underscoring their commitment to long-term growth. For 2025, they expect full-year revenue between $2.3 billion and $2.4 billion, with adjusted EBITDA ranging from $295 million to $335 million, reflecting a 13% margin at the midpoint. In the first quarter alone, revenue grew by 111% year-over-year to $586 million, with adjusted EBITDA nearly tripling to $91 million. The subscriber base expanded to nearly 2.4 million, a 38% increase, with over 70% of new subscribers utilizing personalized solutions. Additionally, the company is focusing on five core growth drivers, including expanding personalization capabilities and entering new specialties, which are expected to propel future engagement and revenue growth.Record Revenue Growth
Revenue grew 111% year-over-year to $586 million in the first quarter of 2025.
Subscriber Base Expansion
The subscriber base grew to nearly 2.4 million, reflecting a year-over-year increase of 38%.
Successful Weight Loss Category Expansion
Weight loss has become one of the company's largest specialties, with significant contributions from a collaboration with Novo Nordisk.
Strong Adjusted EBITDA Performance
Adjusted EBITDA increased to $91 million, nearly tripling from the same quarter last year.
Strategic Partnerships and New Offerings
Partnership with Novo Nordisk and the launch of branded Wegovy expanded the product offerings in the weight loss category.
New COO Appointment
Nader Kabbani, former operations leader at Amazon, was appointed as the new Chief Operating Officer.
---
HIMS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HIMS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2025 | $41.88 | $49.47 | +18.12% |
Feb 24, 2025 | $51.31 | $39.86 | -22.32% |
Nov 04, 2024 | $20.76 | $20.64 | -0.58% |
Aug 05, 2024 | $17.84 | $16.88 | -5.38% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Hims & Hers Health (HIMS) report earnings?
Hims & Hers Health (HIMS) is schdueled to report earning on Aug 11, 2025, TBA Not Confirmed.
What is Hims & Hers Health (HIMS) earnings time?
Hims & Hers Health (HIMS) earnings time is at Aug 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HIMS EPS forecast?
HIMS EPS forecast for the fiscal quarter 2025 (Q2) is 0.15.
---
